Actively Recruiting
Evaluation of Intraocular Pressure Following a Vitreoretinal Surgery Using Goldmann Applanation Tonometry, Icare and Accupen
Led by CHU de Quebec-Universite Laval · Updated on 2024-09-26
67
Participants Needed
1
Research Sites
155 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this prospective controlled study is to measure the reliability of two intraocular pressure (IOP)-measuring instruments in comparison to the gold standard, Goldmann applanation tonometry (GAT) following vitreo-retinal surgery. The main question the current study aims to answer is: are Icare and Accupen as accurate as GAT in measuring IOP one day post eye surgery? Participants in this study will have their IOP measured by the three different instruments one day post-surgery.
CONDITIONS
Official Title
Evaluation of Intraocular Pressure Following a Vitreoretinal Surgery Using Goldmann Applanation Tonometry, Icare and Accupen
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Have received a vitreo-retinal surgery
You will not qualify if you...
- Corneal dystrophy
- Corneal surgery (penetrating keratoplasty, DSAEK/DMEK less than 6 months, radial keratotomy)
- Irregular corneal surface
- Active corneal ulcer
- Active epithelial deficit
- Central corneal scarring
- History of scleral buckle
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hôpital du Saint-Sacrement, CHU de Québec - Université Laval
Québec, Quebec, Canada, G1S4L8
Actively Recruiting
Research Team
J
Julie Mauger, BSc
CONTACT
S
Sébastien Méthot, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here